Integrated Biopharma Inc Q3 FY2024 Earnings Call

Integrated Biopharma Inc (INBP)

Earnings Call FY2024 Q3 Call date: 2024-05-10 Concluded

Quarter scorecard

Revenue

$13.15M

+0.4% YoY

Diluted EPS

$0.01

Gross margin

9.5%

+1.8 pp YoY

Net income

$285,000

+1681.2% YoY

Contract Manufacturing $12.75M

+1.2%

Other Nutraceutical Business $397,000

-20.8%